New therapeutic frontiers for Multiple Sclerosis

Category: Archive Health Medicines Pathologies Photos and illustrations
Tag: #autoimmune diseases #Health #Health Immunologic diseases Multiple sclerosis Woman #immune system #Immunologic diseases #inflammation #lymphocytes #Medicines #mri #Multiple sclerosis
Share:

From personal experience I have been able to verify that in recent years Multiple Sclerosis (MS) increasingly affects early onset, therefore very young people, but I have also been able to appreciate, having worked in a Research and Treatment Center for Multiple Sclerosis, that State-of-the-art therapies visually slow its progression, thus also increasing the quality of life of people with MS. Multiple Sclerosis (MS) is a chronic inflammatory, autoimmune disease that attacks the central nervous system , it is estimated that there are over 400,000 patients in Europe alone, especially young adults. It occurs due to an attack by the immune system itself on the tissues of the organism itself, which is why it is called " autoimmune ". In this specific case, the object of the attack is the myelin sheath which covers the nerve cells and allows the transfer of the signal from one to the other, allowing muscle movement. At the last conference held in Milan by the European Society of Neurology, an innovative study was illustrated which would allow therapy with a few pills a day for 4-6 days a week, with a second cycle a month later and then nothing more for a year. The drug is based on Cladribine, a substance that acts selectively on lymphocytes, generating targeted and long-lasting immunomodulation whose effects last for a year; it is a revolutionary drug because it frees the patient from daily therapy with a prolonged administration over time, but also because it has demonstrated double efficacy, showing an 80% reduction in lesions on magnetic resonance imaging after six months and an 85% decrease in attacks %.

Published: 2022-12-28From: Marketing

You may also like

Hair Loss Treatments: Symptoms, Causes and Innovations for Men and Women

Hair loss remains a prevalent issue manifesting differently in men and women due to various causes and geographic influences. This article delves into the symptoms, traditional and experimental treatments, incorporating insights into skin conditions like acne and psoriasis, as well as advances in dental care.

2025-03-10Marketing

Acne: Symptoms, Treatments and Innovations in Dermatology

Acne is a common skin condition affecting both teenagers and adults, characterized by various symptoms and requiring a range of treatment options. This article explores the incidence and impact of acne worldwide, the specific challenges faced by teenagers and adults, and highlights cutting-edge treatments and ongoing research. Additionally, it touches on related dermatological issues such as hair loss, atopic dermatitis, psoriasis, and oral health.

2025-03-10Marketing

Atopic Dermatitis: Understanding Symptoms, Treatments and New Research Developments

Atopic dermatitis, a prevalent skin condition, affects millions worldwide, posing unique challenges to dermatologists and patients alike. This article explores the symptoms, traditional and innovative treatments, and ongoing research in combating both atopic dermatitis and psoriasis. Additionally, it delves into related conditions such as hair loss, acne, and dental care, providing a comprehensive overview of the latest advancements in dermatology.

2025-03-10Marketing

The Emerging Frontier in Dental Implants and Hygiene

This article delves into the multifaceted world of dental implants and oral hygiene. It provides an in-depth analysis of various methods and treatments, discusses common issues and challenges, and explores pioneering studies on dental implants currently under experimentation. Additionally, the article reviews correlations between oral health and other dermatological issues, including hair loss, atopic dermatitis, psoriasis, and acne.

2025-03-10Marketing